Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Phase I trial commences for Lu-AA-24493 in acute ischemic stroke

Oct. 23, 2007

Innocoll files IND for CollaRx bupivacaine topical

Oct. 23, 2007

Targin improves opioid-induced bowel dysfunction in patients with chronic pain

Oct. 22, 2007

Neuroprotection by C2-8, a polyglutamine aggregation inhibitor, in Huntington's disease model

Oct. 22, 2007

Analysis of phase III desmoteplase trial justifies continued development

Oct. 22, 2007

Affectis initiates phase II trial for cimicoxib in depression

Oct. 22, 2007

EnVivo reports progress on major drug programs

Oct. 22, 2007

Alte Biosciences secures rights for therapeutics targeting late-onset depression

Oct. 22, 2007

Efficacy, tolerability of tapentadol immediate release assessed in acute pain following bunionectomy

Oct. 19, 2007

Forest and Gedeon report results from cariprazine phase II trial for schizophrenia

Oct. 19, 2007

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026